Program: 2024 Continuing Education Webinars
Times: 1 - 2 PM EST
Duration: 60.783333333333 minutes
Event status: Not started
Upon Completion of this CE program, the audience will understand immunoglobulin therapy including administration, disease states used in therapy and treatment options. The CE program will provide information on the neurological diseases associated with immunoglobulin therapy and provide insights on therapy options.
Program: 2024 Continuing Education Webinars
Times: 1 - 2 PM EST
Duration: 60 minutes
Event status: Not started
Upon completion of this CE Program, the audience will understand breast cancer and the various subtypes that comprise the disease as well as a focused review of hormone receptor-positive (HR+) breast cancer risk factors and therapies. The CE will provide information on the treatment landscape for advanced disease, including current marketed specialty products and near-term pipeline agents.
Program: 2024 Continuing Education Webinars
Times: 1 - 2 PM EST
Duration: 60 minutes
Event status: Not started